In the coming days curative therapies will change the face of the healthcare system.
HealthQuad, an India-focused healthcare venture capital firm, has raised $162 million in the final close of its second fund.
NTAGI will review this week’s data of Serum Institute of India’s anti-coronavirus jab Covovax to decide inclusion in the national COVID-19 vaccination programme for inoculating children aged 12 years and above, official said yesterday.
BioNTech said on Wednesday it would extend an ongoing clinical trial programme to produce new vaccines and patterns of administration for better protection against the dominant Omicron coronavirus variant.
Sun Pharma on Wednesday said it has entered into an exclusive patent licensing agreement with Danish-drugmaker Lundbeck to market and distribute its own version of antidepressant medication Vortioxetine in India under the brand name Vortidiftm.
UnitedHealth Group said on Tuesday it would purchase LHC Group for about $5.4 billion in cash, as the largest U.S. health insurer expands its home health services.
Strides Pharma on Tuesday said its founder-promoter Arun Kumar will be assuming executive role as executive chairperson and managing Director effective April 7.
India’s free trade pact with the UAE eliminated tariffs on finished pharmaceutical goods but restricted access to the gulf nation’s energy resources.
Alembic Pharmaceuticals on Tuesday said it has acquired the balance 40% stake in Aleor Dermaceuticals from its JV Partner Orbicular Pharmaceutical Technologies to strengthen its skin-related built-up and marketing footprint.
Drug maker Aurobindo Pharma on Monday said it has acquired the domestic formulations business of Veritaz for Rs 171 crore on debt free and cash-free basis.
, CDSCO.jpg)
